Treatment of patients with hypertension who are infected with the severe acute respiratory syndrome coronavirus 2 with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers may improve clinical outcomes.
Only 5.5% of the devices stocked by international e-commerce businesses validated.
Elevated serum uric acid (SUA) levels are associated with development of hypertension and vascular and renal target organ damage, according to a new long-term study. Investigators studied 961 parents and 570 children who were initially healthy at the time of recruitment into the STANISLAS cohort, a single-center familial longitudinal cohort that began recruiting patients in…
Second study shows ambulatory BP patterns not tied to cognitive impairment or frailty in CKD patients
The Centers for Disease Control and Prevention has updated the guidance for evaluation of persons under investigation for coronavirus disease 2019 (COVID-19), expanding the criteria to a wider group of symptomatic patients.
Study findings suggest the benefits of continuing ACEi or ARB therapy outweigh the risks in CKD patients with an eGFR less than 30 mL/min/1.73 m2.
Mean survival benefits varied from 6 months to 3 years for intensive versus standard BP control.
No cardiovascular benefits found with chlorthalidone versus hydrochlorothiazide for hypertension treatment.
Compared with chlorthalidone and lisinopril, amlodipine associated with lower risk for gout.
Medication doses do not need to be reduced in response to symptomless orthostatic hypotension, authors say.
